ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 173 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $123 | -47.7% | 11 | 0.0% | 0.00% | – |
| Q2 2023 | $235 | -47.2% | 11 | 0.0% | 0.00% | – |
| Q1 2023 | $445 | -55.5% | 11 | 0.0% | 0.00% | – |
| Q4 2022 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | -83.3% | 11 | -84.9% | 0.00% | – |
| Q4 2021 | $6,000 | +100.0% | 73 | +40.4% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 52 | -20.0% | 0.00% | – |
| Q2 2021 | $3,000 | 0.0% | 65 | 0.0% | 0.00% | – |
| Q1 2021 | $3,000 | 0.0% | 65 | -1.5% | 0.00% | – |
| Q4 2020 | $3,000 | 0.0% | 66 | -17.5% | 0.00% | – |
| Q3 2020 | $3,000 | +200.0% | 80 | +135.3% | 0.00% | – |
| Q2 2020 | $1,000 | – | 34 | +1600.0% | 0.00% | – |
| Q1 2020 | $0 | – | 2 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |